https://www.sciencedaily.com/news/health_medicine/restless_leg_syndrome/ Read recent research on restless leg syndrome and related conditions, including new treatment approaches and experimental medicines. en-us Fri, 13 Mar 2026 06:15:27 EDT Fri, 13 Mar 2026 06:15:27 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/restless_leg_syndrome/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/03/260306145621.htm Researchers have discovered a new way to increase a key brain protein damaged in Rett syndrome, a rare genetic disorder that affects thousands of children worldwide. Early studies in mice and patient-derived cells show the approach can restore normal brain cell function, raising hopes for future therapies. Fri, 06 Mar 2026 21:18:09 EST https://www.sciencedaily.com/releases/2026/03/260306145621.htm https://www.sciencedaily.com/releases/2026/02/260219040820.htm A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is driven by the gradual loss of dopamine-producing cells—leading to tremors, stiffness, and slowed movement—researchers are implanting lab-grown cells directly into the brain’s movement center to replace what’s been lost. Fri, 20 Feb 2026 04:03:58 EST https://www.sciencedaily.com/releases/2026/02/260219040820.htm https://www.sciencedaily.com/releases/2026/01/260129080428.htm A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that process down. Researchers found that SGLT2 inhibitors, widely used to treat diabetes and heart disease, preserved kidney structure, blood vessels, and energy production as the fish aged, while also calming inflammation. The results help explain why these drugs protect kidneys and hearts so reliably in people, even beyond blood sugar control. Fri, 30 Jan 2026 07:31:31 EST https://www.sciencedaily.com/releases/2026/01/260129080428.htm https://www.sciencedaily.com/releases/2026/01/260121034146.htm A major global study suggests that a hidden mismatch between two common blood tests could quietly signal serious trouble ahead. When results from creatinine and cystatin C—two markers used to assess kidney health—don’t line up, the risk of kidney failure, heart disease, and even death appears to rise sharply. Researchers found that this gap is especially common among hospitalized and older patients, and that relying on just one test may miss early warning signs. Wed, 21 Jan 2026 12:19:18 EST https://www.sciencedaily.com/releases/2026/01/260121034146.htm https://www.sciencedaily.com/releases/2026/01/260120095116.htm Scientists have uncovered why people with chronic kidney disease so often die from heart problems: damaged kidneys release tiny particles into the bloodstream that actively poison the heart. These particles, produced only by diseased kidneys, carry genetic material that disrupts heart function and can lead to heart failure. Tue, 20 Jan 2026 10:40:35 EST https://www.sciencedaily.com/releases/2026/01/260120095116.htm https://www.sciencedaily.com/releases/2026/01/260120000305.htm A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved gut bacteria, boosted serotonin, and lowered harmful cholesterol and bile acids. Surprisingly, it also reduced circulating levels of antiretroviral drugs while maintaining viral suppression, potentially protecting the liver. Scientists say the results point to a promising new approach for managing chronic complications of HIV. Wed, 21 Jan 2026 01:36:19 EST https://www.sciencedaily.com/releases/2026/01/260120000305.htm https://www.sciencedaily.com/releases/2026/01/260112001001.htm Most U.S. adults have risk factors tied to a little-known condition called CKM syndrome, which connects heart disease, kidney problems, diabetes, and obesity into one powerful health threat. When these issues overlap, the danger rises far more than when they occur alone. Despite low awareness, people are eager to learn how CKM is diagnosed and treated. Experts say understanding how these systems work together could prevent serious, life-threatening events. Mon, 12 Jan 2026 00:10:01 EST https://www.sciencedaily.com/releases/2026/01/260112001001.htm https://www.sciencedaily.com/releases/2026/01/260105165817.htm Researchers at USF Health have discovered a new way opioid receptors can work that may lead to safer pain medications. Their findings show that certain experimental compounds can amplify pain relief without intensifying dangerous side effects like suppressed breathing. This research offers a fresh blueprint for designing opioids that last longer, work better, and pose fewer risks. It also opens doors to safer treatments for other brain disorders. Tue, 06 Jan 2026 06:27:34 EST https://www.sciencedaily.com/releases/2026/01/260105165817.htm https://www.sciencedaily.com/releases/2025/12/251221043225.htm A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly enables movement in the background, much like oil in an engine. When scientists manipulated dopamine during movement, nothing changed—but restoring baseline dopamine levels made a big difference. The finding could reshape how Parkinson’s disease is treated. Mon, 22 Dec 2025 01:38:31 EST https://www.sciencedaily.com/releases/2025/12/251221043225.htm https://www.sciencedaily.com/releases/2025/12/251205045845.htm A large study found that people with impaired kidneys tend to have higher Alzheimer’s biomarkers, yet they don’t face a higher overall risk of dementia. For those who already have elevated biomarkers, kidney problems may speed up when symptoms appear. The findings show that kidney health can change how Alzheimer’s blood tests are read. Doctors may need to consider both organs to get a clearer picture. Fri, 05 Dec 2025 05:19:42 EST https://www.sciencedaily.com/releases/2025/12/251205045845.htm https://www.sciencedaily.com/releases/2025/11/251121090729.htm Researchers discovered that chemotherapy can accidentally trigger a stress alarm in immune cells, causing inflammation that damages nerves. Blocking this alarm protected mice from nerve pain and kept their nerves healthier. A drug already being tested for cancer may help do the same in people. Early blood tests suggest it may even be possible to predict who will develop these symptoms before they happen. Fri, 21 Nov 2025 11:02:54 EST https://www.sciencedaily.com/releases/2025/11/251121090729.htm https://www.sciencedaily.com/releases/2025/11/251118212039.htm A nationwide analysis has uncovered how sprawling fossil fuel infrastructure sits surprisingly close to millions of American homes. The research shows that 46.6 million people live within about a mile of wells, refineries, pipelines, storage sites, or transport facilities. Many of these locations release pollutants that may affect nearby communities, yet mid-supply-chain sites have rarely been studied. The findings reveal major gaps in understanding how this hidden network affects health. Thu, 20 Nov 2025 09:09:30 EST https://www.sciencedaily.com/releases/2025/11/251118212039.htm https://www.sciencedaily.com/releases/2025/11/251117095646.htm Chronic kidney disease has surged to nearly 800 million cases and is now among the top causes of death worldwide. The condition is heavily linked to diabetes, hypertension, and obesity, and often goes unnoticed until late stages. Many countries lack access to dialysis and transplants, leaving millions without adequate care. Tue, 18 Nov 2025 10:07:29 EST https://www.sciencedaily.com/releases/2025/11/251117095646.htm https://www.sciencedaily.com/releases/2025/11/251114094525.htm Researchers uncovered how fatty molecules called ceramides trigger acute kidney injury by damaging the mitochondria that power kidney cells. By altering ceramide metabolism or using a new drug candidate, the team was able to protect mitochondrial function and completely prevent kidney injury in mice. Fri, 14 Nov 2025 21:40:47 EST https://www.sciencedaily.com/releases/2025/11/251114094525.htm https://www.sciencedaily.com/releases/2025/11/251103092957.htm Duke-NUS scientists unveiled BrainSTEM, a revolutionary single-cell map that captures the full cellular diversity of the developing human brain. The project’s focus on dopamine neurons provides crucial insight for Parkinson’s treatment. Their findings reveal flaws in current lab-grown models while offering a precise, open-source standard for future research. It’s a leap toward more accurate brain modeling and powerful cell-based therapies. Mon, 03 Nov 2025 10:09:14 EST https://www.sciencedaily.com/releases/2025/11/251103092957.htm https://www.sciencedaily.com/releases/2025/10/251008030947.htm A new pill called baxdrostat may offer hope for people whose blood pressure stays high even after taking standard medications. In a recent study, the drug lowered blood pressure and also seemed to protect the kidneys by reducing signs of damage. Doctors say this could help millions of people with chronic kidney disease, a condition that often makes blood pressure harder to control. Wed, 08 Oct 2025 23:01:32 EDT https://www.sciencedaily.com/releases/2025/10/251008030947.htm https://www.sciencedaily.com/releases/2025/09/250912195133.htm Scientists discovered that a gut bacteria molecule called corisin can travel to the kidneys, triggering inflammation and scarring that lead to diabetic kidney fibrosis. By attaching to albumin in the blood, corisin infiltrates kidney tissue and accelerates damage. In animal studies, antibodies that neutralize corisin slowed disease progression, offering hope for new treatments beyond dialysis and transplants. Fri, 12 Sep 2025 20:41:29 EDT https://www.sciencedaily.com/releases/2025/09/250912195133.htm https://www.sciencedaily.com/releases/2025/09/250902085158.htm Overactivation of dopamine neurons may directly drive their death, explaining why movement-controlling brain cells degenerate in Parkinson’s. Mice with chronically stimulated neurons showed the same selective damage seen in patients, along with molecular stress responses. Targeting this overactivity could help slow disease progression. Wed, 03 Sep 2025 04:57:28 EDT https://www.sciencedaily.com/releases/2025/09/250902085158.htm https://www.sciencedaily.com/releases/2025/07/250718031201.htm President Trump s diagnosis of Chronic Venous Insufficiency (CVI) has brought renewed attention to a frequently overlooked yet dangerous condition. CVI affects the ability of veins especially in the legs to return blood to the heart, often leading to swelling, pain, skin changes, and ulcers. The American Heart Association warns that CVI isn t just a cosmetic issue; it's strongly linked to cardiovascular disease and increased mortality, even when other risk factors are accounted for. Seniors, smokers, those with sedentary lifestyles, and people with obesity are particularly at risk. Fri, 18 Jul 2025 03:12:01 EDT https://www.sciencedaily.com/releases/2025/07/250718031201.htm https://www.sciencedaily.com/releases/2025/07/250703230641.htm Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective signals in a mouse model of genetic Parkinson’s. After three months on the LRRK2-blocking drug MLi-2, damaged circuits revived and early signs of neuronal recovery emerged, hinting that timely treatment could not only halt but reverse disease progression—and perhaps benefit other Parkinson’s forms. Thu, 03 Jul 2025 23:44:37 EDT https://www.sciencedaily.com/releases/2025/07/250703230641.htm https://www.sciencedaily.com/releases/2025/05/250527124435.htm Scientists have identified microRNA able to protect small blood vessels and support kidney function after severe injury. Tue, 27 May 2025 12:44:35 EDT https://www.sciencedaily.com/releases/2025/05/250527124435.htm https://www.sciencedaily.com/releases/2025/05/250521204008.htm People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study. Wed, 21 May 2025 20:40:08 EDT https://www.sciencedaily.com/releases/2025/05/250521204008.htm https://www.sciencedaily.com/releases/2025/05/250521124256.htm SSRIs boosted the ability of T cells to kill cancer cells and suppressed tumor growth in both mouse and human tumor models. Wed, 21 May 2025 12:42:56 EDT https://www.sciencedaily.com/releases/2025/05/250521124256.htm https://www.sciencedaily.com/releases/2025/05/250521124120.htm With its fascinating ability to regrow entire limbs and internal organs, the Mexican axolotl is the ideal model for studying regeneration. Scientists have now found a factor that tells cells which part of the arm to regenerate -- and used it to reprogram the identity of cells as they develop. This breakthrough for the regeneration research field has implications for tissue engineering, including in human tissues. Wed, 21 May 2025 12:41:20 EDT https://www.sciencedaily.com/releases/2025/05/250521124120.htm https://www.sciencedaily.com/releases/2025/05/250519131126.htm A breakthrough drug from Duke University, SBI-810, promises strong pain relief without the pitfalls of opioids. Unlike traditional painkillers that trigger multiple brain pathways—and often addiction—SBI-810 activates just one specific pathway tied to pain relief, sidestepping the euphoric high, constipation, and tolerance buildup common with opioids. It worked impressively in mice, reducing pain from surgery, fractures, and nerve damage—sometimes outperforming even hospital-grade opioids and gabapentin. Even better, it made opioids more effective at lower doses when used together. Mon, 19 May 2025 13:11:26 EDT https://www.sciencedaily.com/releases/2025/05/250519131126.htm https://www.sciencedaily.com/releases/2025/05/250515131950.htm A new study suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM) -- the most common and deadly form of brain cancer in adults. The findings are based on a retrospective analysis and add new evidence to help patients with this devastating disease. Thu, 15 May 2025 13:19:50 EDT https://www.sciencedaily.com/releases/2025/05/250515131950.htm https://www.sciencedaily.com/releases/2025/05/250514111059.htm Neuroscientists have discovered that the brain uses a dual system for learning through trial and error. This is the first time a second learning system has been identified, which could help explain how habits are formed and provide a scientific basis for new strategies to address conditions related to habitual learning, such as addictions and compulsions. The study in mice could also have implications for developing therapeutics for Parkinson's. Wed, 14 May 2025 11:10:59 EDT https://www.sciencedaily.com/releases/2025/05/250514111059.htm https://www.sciencedaily.com/releases/2025/05/250507130615.htm Groundbreaking device instantly detects dangerous street drugs, offering hope for harm reduction A portable device that instantly detects illicit street drugs at very low concentrations, thereby highlighting the risks they pose. The device has the potential to address the growing global problem of people unknowingly taking drugs that have been mixed with undeclared substances, including synthetic opioids such as fentanyl and nitazenes. Wed, 07 May 2025 13:06:15 EDT https://www.sciencedaily.com/releases/2025/05/250507130615.htm https://www.sciencedaily.com/releases/2025/04/250430142231.htm Researchers have identified the neural mechanisms in the brain that regulate both positive and negative impressions of a social encounter, as well as how an imbalance between the two could lead to common neuropsychiatric disorders. Wed, 30 Apr 2025 14:22:31 EDT https://www.sciencedaily.com/releases/2025/04/250430142231.htm https://www.sciencedaily.com/releases/2025/04/250416135728.htm Focal cortical dysplasia (FCD) type 2 is a congenital malformation of the cerebral cortex that is often associated with difficult-to-treat epilepsy. In the affected areas, nerve cells and their layer structures are arranged in an atypical manner, which often makes drug therapy more difficult. A research team has now found evidence of profound changes in the dopamine system in FCD type 2. Wed, 16 Apr 2025 13:57:28 EDT https://www.sciencedaily.com/releases/2025/04/250416135728.htm https://www.sciencedaily.com/releases/2025/04/250409154851.htm A new study found that people with cannabis use disorder (CUD) had elevated dopamine levels in a brain region associated with psychosis. Wed, 09 Apr 2025 15:48:51 EDT https://www.sciencedaily.com/releases/2025/04/250409154851.htm https://www.sciencedaily.com/releases/2025/04/250409154607.htm Researchers have identified type 5 collagen as a key factor in kidney fibrosis, revealing its potential as a biomarker to predict chronic kidney disease progression. A repurposed anti-cancer drug, Cilengitide, was found to reduce kidney scarring and slow disease progression in preclinical models, suggesting a possible precision medicine approach for high-risk patients. The team now seeks to develop a blood test to measure type 5 collagen levels, which could help identify patients at greater risk for kidney failure and guide targeted treatment strategies. Wed, 09 Apr 2025 15:46:07 EDT https://www.sciencedaily.com/releases/2025/04/250409154607.htm https://www.sciencedaily.com/releases/2025/04/250408121327.htm In the first comprehensive, cell-by-cell analysis of brain tissue from individuals with Tourette syndrome, researchers have pinpointed exactly which cells are perturbed and how they malfunction, revealing how different types of brain cells are affected by the condition. Findings from this groundbreaking study provide unprecedented insights into the interplay of different brain cell types in Tourette syndrome, suggesting new therapeutic directions. Tue, 08 Apr 2025 12:13:27 EDT https://www.sciencedaily.com/releases/2025/04/250408121327.htm https://www.sciencedaily.com/releases/2025/03/250328112547.htm Scientists have confirmed a neurobiochemical link between dopamine and cognitive flexibility. PET imaging shows that the brain increases dopamine production when completing cognitively demanding tasks, and that the more dopamine released, the more efficiently the tasks are completed. Armed with this information, physicians may soon be able to develop more precise treatment strategies for neurological and psychiatric disorders. Fri, 28 Mar 2025 11:25:47 EDT https://www.sciencedaily.com/releases/2025/03/250328112547.htm https://www.sciencedaily.com/releases/2025/03/250326122652.htm Why do some people lose the joy of eating, even when surrounded by irresistible foods? UC Berkeley researchers have uncovered a surprising brain mechanism that explains this paradox. They found that a high-fat diet lowers levels of a peptide called neurotensin, which normally boosts dopamine’s pleasure response. Without it, food loses its appeal — driving people to eat out of habit rather than enjoyment, which can fuel obesity. Wed, 26 Mar 2025 12:26:52 EDT https://www.sciencedaily.com/releases/2025/03/250326122652.htm https://www.sciencedaily.com/releases/2025/03/250312190837.htm New research expands on current understanding of the brain chemical dopamine, finding that it plays a role in reducing the value of memories associated with rewards. The study opens new avenues for understanding dopamine's role in the brain. Wed, 12 Mar 2025 19:08:37 EDT https://www.sciencedaily.com/releases/2025/03/250312190837.htm https://www.sciencedaily.com/releases/2025/03/250309203153.htm A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to replace dopamine cells in the brain. The clinical trial, based on more than three decades of research, has treated three-of-six participants who will be tracked for more than a year. Sun, 09 Mar 2025 20:31:53 EDT https://www.sciencedaily.com/releases/2025/03/250309203153.htm https://www.sciencedaily.com/releases/2025/02/250225122454.htm New research suggests that certain antidepressants can accelerate cognitive decline in people with dementia. At the same time, some drugs appear to be less harmful than others, which can help doctors make better treatment decisions, according to the study. Tue, 25 Feb 2025 12:24:54 EST https://www.sciencedaily.com/releases/2025/02/250225122454.htm https://www.sciencedaily.com/releases/2025/02/250221125541.htm The combination of prescribed central nervous system stimulants, such as drugs that relieve ADHD symptoms, with prescribed opioid medications is associated with a pattern of escalating opioid intake, a new study has found. Fri, 21 Feb 2025 12:55:41 EST https://www.sciencedaily.com/releases/2025/02/250221125541.htm https://www.sciencedaily.com/releases/2025/02/250219110023.htm War study in Ukraine suggests hydrodissection may reduce pain, opioid use in amputees. Wed, 19 Feb 2025 11:00:23 EST https://www.sciencedaily.com/releases/2025/02/250219110023.htm https://www.sciencedaily.com/releases/2025/02/250211134903.htm Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map' of kidney function to date, the researchers have paved the way for more precise diagnosing of kidney disease, strategies to prevent it, and ways to treat it. Tue, 11 Feb 2025 13:49:03 EST https://www.sciencedaily.com/releases/2025/02/250211134903.htm https://www.sciencedaily.com/releases/2025/02/250211134148.htm The pleasurable urge to move to music -- to groove -- appears to be a physiological response independent of how much we generally enjoy music, according to a new article. That groove response is so strong it is even found in people with musical anhedonia, those who take little or no pleasure from music. Researchers compared groove responses to more than 50 short pieces of music in people with musical anhedonia and non-anhedonic controls and found that for people with anhedonia, the urge to move appears to drive their experience of pleasure. That suggests that the blunted pleasure sensation found in people with musical anhedonia is compensated by the urge to move. Tue, 11 Feb 2025 13:41:48 EST https://www.sciencedaily.com/releases/2025/02/250211134148.htm https://www.sciencedaily.com/releases/2025/02/250203163839.htm For those over 40, it's a common injury with different treatment options to try. Mon, 03 Feb 2025 16:38:39 EST https://www.sciencedaily.com/releases/2025/02/250203163839.htm https://www.sciencedaily.com/releases/2025/01/250122125615.htm Like humans, mice will compete over territory and mates, and show increased confidence in their fighting skills the more they win. At first, a brain chemical called dopamine is essential for young males to master this behavior. But as they gain experience, the chemical grows less important in promoting aggression, a new study shows. Wed, 22 Jan 2025 12:56:15 EST https://www.sciencedaily.com/releases/2025/01/250122125615.htm https://www.sciencedaily.com/releases/2025/01/250106132328.htm Researchers find an over-the-counter combo is more effective for wisdom tooth extraction pain. Mon, 06 Jan 2025 13:23:28 EST https://www.sciencedaily.com/releases/2025/01/250106132328.htm https://www.sciencedaily.com/releases/2024/12/241220132846.htm When you are feeling hungry, the brain takes the necessary steps toward consuming a meal. Many of these steps are not well known, but a new study reveals brain circuits and chemical messengers that contribute to the regulation of meal initiation and food intake. The findings have implications for the development of improved therapies to manage obesity, a worldwide epidemic. Fri, 20 Dec 2024 13:28:46 EST https://www.sciencedaily.com/releases/2024/12/241220132846.htm https://www.sciencedaily.com/releases/2024/12/241211190058.htm In animal studies, boosting serotonin in the cells that line the gut reduced anxious and depressive-like behaviors without causing cognitive or gastrointestinal side effects. Wed, 11 Dec 2024 19:00:58 EST https://www.sciencedaily.com/releases/2024/12/241211190058.htm https://www.sciencedaily.com/releases/2024/12/241211124740.htm Researchers have found definitive proof of a kidney microbiome that influences renal health and kidney stone formation, demonstrating that the urinary tract is not sterile and low levels of bacteria are normal. The publication describes the rigorous multi-pronged approach a team used to identify and characterize the small bacterial community by combining preclinical, human and dish studies. Wed, 11 Dec 2024 12:47:40 EST https://www.sciencedaily.com/releases/2024/12/241211124740.htm https://www.sciencedaily.com/releases/2024/12/241209203730.htm New research provides valuable insights into the brain-body immune connection identifying key communication hubs in the dural sinuses and skull bone marrow at the back of the head. Mon, 09 Dec 2024 20:37:30 EST https://www.sciencedaily.com/releases/2024/12/241209203730.htm https://www.sciencedaily.com/releases/2024/12/241209163205.htm Studying the cells of people and genetically engineered mice, scientists say they have uncovered a potential reason why patients with Loeys-Dietz syndrome, an inherited connective tissue disorder, are especially prone to developing aneurysms at the root of the aorta. Mon, 09 Dec 2024 16:32:05 EST https://www.sciencedaily.com/releases/2024/12/241209163205.htm https://www.sciencedaily.com/releases/2024/12/241202123655.htm Increasing the levels of chemicals naturally produced in the body called endocannabinoids may thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs' ability to relieve pain, according to a new study. Endocannabinoids bind to cannabinoid receptors throughout the body that regulate activities, such as learning and memory, emotions, sleep, immune response and appetite. Mon, 02 Dec 2024 12:36:55 EST https://www.sciencedaily.com/releases/2024/12/241202123655.htm https://www.sciencedaily.com/releases/2024/11/241125195050.htm The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes. Mon, 25 Nov 2024 19:50:50 EST https://www.sciencedaily.com/releases/2024/11/241125195050.htm https://www.sciencedaily.com/releases/2024/11/241121115650.htm Scientists have discovered how long-term treatment of high blood pressure with commonly prescribed drugs can destroy the kidney's ability to filter and purify blood. The finding could open the door to better ways to manage high blood pressure and other vascular diseases. Thu, 21 Nov 2024 11:56:50 EST https://www.sciencedaily.com/releases/2024/11/241121115650.htm https://www.sciencedaily.com/releases/2024/11/241113123447.htm A new clinical practice guideline provides updated recommendations for the treatment of restless legs syndrome. The guideline reflects the latest scientific evidence and recommends significant changes in the standard treatment of RLS in adults. Wed, 13 Nov 2024 12:34:47 EST https://www.sciencedaily.com/releases/2024/11/241113123447.htm https://www.sciencedaily.com/releases/2024/10/241028164210.htm Researches made major strides toward the creation of artificial kidney tissue by demonstrating an undiscovered mechanism behind kidney development and a novel technique for culturing kidney cells, both of which could ultimately reduce the need for both dialysis and transplantation. Mon, 28 Oct 2024 16:42:10 EDT https://www.sciencedaily.com/releases/2024/10/241028164210.htm https://www.sciencedaily.com/releases/2024/10/241028131454.htm A study has revealed a significant genetic risk factor for kidney disease in people from Ghana and Nigeria. Their study demonstrated that having just one risk variant in a gene known as APOL1 can significantly increase the risk of developing kidney disease. APOL1 is important for the immune system and variants of the gene are linked to increased risk of chronic kidney disease. The study is published in the New England Journal of Medicine and was conducted by researchers from the Human Heredity and Health in Africa (H3Africa) Kidney Disease Research Network. Mon, 28 Oct 2024 13:14:54 EDT https://www.sciencedaily.com/releases/2024/10/241028131454.htm https://www.sciencedaily.com/releases/2024/10/241024130759.htm A new scientific statement released today by the Endocrine Society highlights research gaps associated with the negative effects of opioid use on the endocrine system. Thu, 24 Oct 2024 13:07:59 EDT https://www.sciencedaily.com/releases/2024/10/241024130759.htm https://www.sciencedaily.com/releases/2024/10/241023141809.htm A team has developed a device that may rescue people from overdose without bystander help. In animal studies, the researchers found that the implantable device detects an overdose, rapidly delivers naloxone to prevent death and can alert emergency first responders. Wed, 23 Oct 2024 14:18:09 EDT https://www.sciencedaily.com/releases/2024/10/241023141809.htm https://www.sciencedaily.com/releases/2024/10/241017113517.htm It is just as safe and effective for people with HIV in need of kidney transplantation to get their organ from donors who are also HIV positive as it is from donors who are not infected with the virus, a study shows. Survival rates for organ recipients one and three years after the procedure were the same for donors with or without HIV. Thu, 17 Oct 2024 11:35:17 EDT https://www.sciencedaily.com/releases/2024/10/241017113517.htm https://www.sciencedaily.com/releases/2024/10/241016120023.htm According to new research, men and women rely on different biological systems for pain relief, which could help explain why our most powerful pain medications are often less effective in women. Wed, 16 Oct 2024 12:00:23 EDT https://www.sciencedaily.com/releases/2024/10/241016120023.htm